News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,845 Results
Type
Article (42419)
Company Profile (295)
Press Release (673131)
Section
Business (210438)
Career Advice (2092)
Deals (36637)
Drug Delivery (106)
Drug Development (83038)
Employer Resources (175)
FDA (16550)
Job Trends (15399)
News (356007)
Policy (33892)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2593)
Accelerated approval (2)
Adcomms (21)
Allergies (84)
Alliances (51377)
ALS (85)
Alzheimer's disease (1364)
Antibody-drug conjugate (ADC) (115)
Approvals (16551)
Artificial intelligence (242)
Autoimmune disease (15)
Automation (14)
Bankruptcy (372)
Best Places to Work (11773)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (189)
Bladder cancer (56)
Brain cancer (26)
Breast cancer (248)
Cancer (2007)
Cardiovascular disease (163)
Career advice (1750)
Career pathing (30)
CAR-T (141)
Cell therapy (398)
Cervical cancer (18)
Clinical research (67233)
Collaboration (781)
Compensation (451)
Complete response letters (25)
COVID-19 (2653)
CRISPR (40)
C-suite (209)
Cystic fibrosis (101)
Data (1930)
Decentralized trials (2)
Denatured (26)
Depression (39)
Diabetes (251)
Diagnostics (6416)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (114)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (85)
Earnings (87845)
Editorial (33)
Employer branding (21)
Employer resources (149)
Events (114512)
Executive appointments (643)
FDA (17666)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (694)
Gene editing (101)
Generative AI (20)
Gene therapy (289)
GLP-1 (719)
Government (4500)
Grass and pollen (4)
Guidances (48)
Healthcare (19000)
Huntington's disease (23)
IgA nephropathy (22)
Immunology and inflammation (112)
Indications (27)
Infectious disease (2782)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (85)
Interviews (322)
IPO (16766)
IRA (47)
Job creations (4056)
Job search strategy (1493)
Kidney cancer (9)
Labor market (34)
Layoffs (471)
Leadership (16)
Legal (8367)
Liver cancer (71)
Lung cancer (291)
Lymphoma (131)
Machine learning (2)
Management (59)
Manufacturing (277)
MASH (62)
Medical device (13409)
Medtech (13414)
Mergers & acquisitions (20331)
Metabolic disorders (651)
Multiple sclerosis (68)
NASH (18)
Neurodegenerative disease (81)
Neuropsychiatric disorders (26)
Neuroscience (1845)
NextGen: Class of 2025 (6648)
Non-profit (4535)
Northern California (2407)
Now hiring (37)
Obesity (354)
Opinion (227)
Ovarian cancer (73)
Pain (85)
Pancreatic cancer (77)
Parkinson's disease (131)
Partnered (20)
Patents (207)
Patient recruitment (94)
Peanut (49)
People (59056)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20848)
Phase II (29586)
Phase III (22180)
Pipeline (984)
Podcasts (74)
Policy (120)
Postmarket research (2654)
Preclinical (8836)
Press Release (68)
Prostate cancer (93)
Psychedelics (31)
Radiopharmaceuticals (250)
Rare diseases (369)
Real estate (6258)
Recruiting (67)
Regulatory (22993)
Reports (46)
Research institute (2367)
Resumes & cover letters (358)
Rett syndrome (3)
RNA editing (3)
RSV (37)
Schizophrenia (70)
Series A (123)
Series B (78)
Service/supplier (12)
Sickle cell disease (52)
Southern California (2079)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3725)
State (2)
Stomach cancer (14)
Supply chain (60)
The Weekly (45)
United States (21144)
Vaccines (675)
Venture capitalists (37)
Webinars (12)
Weight loss (242)
Women's health (33)
Worklife (15)
Date
Today (125)
Last 7 days (605)
Last 30 days (2560)
Last 365 days (34124)
2025 (7886)
2024 (35784)
2023 (40643)
2022 (51808)
2021 (56341)
2020 (54811)
2019 (47431)
2018 (35797)
2017 (33165)
2016 (32687)
2015 (38627)
2014 (32530)
2013 (27645)
2012 (29744)
2011 (30499)
2010 (28506)
Location
Africa (781)
Alabama (49)
Alaska (7)
Arizona (230)
Arkansas (14)
Asia (40590)
Australia (6508)
California (5493)
Canada (1868)
China (480)
Colorado (247)
Connecticut (258)
Delaware (127)
Europe (86556)
Florida (812)
Georgia (190)
Idaho (57)
Illinois (502)
India (24)
Indiana (298)
Iowa (9)
Japan (144)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (834)
Massachusetts (4165)
Michigan (211)
Minnesota (368)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1574)
New Mexico (29)
New York (1575)
North Carolina (934)
North Dakota (7)
Northern California (2407)
Ohio (190)
Oklahoma (14)
Oregon (38)
Pennsylvania (1251)
Puerto Rico (9)
Rhode Island (26)
South America (1162)
South Carolina (18)
South Dakota (1)
Southern California (2079)
Tennessee (92)
Texas (823)
Utah (165)
Virginia (135)
Washington D.C. (57)
Washington State (516)
West Virginia (3)
Wisconsin (51)
715,845 Results for "catalyst pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
March 4, 2025
·
2 min read
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst’s management team, will participate at the upcoming Jefferies Global Healthcare Conference 2024 on Wednesday, June 5, 2024, in New York.
May 28, 2024
·
3 min read
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
Catalyst Pharmaceuticals, Inc. today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst’s management team, will participate at the upcoming BofA Securities Health Care Conference.
May 1, 2024
·
3 min read
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
Catalyst Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (“FDA”) has approved its supplemental New Drug Application (“sNDA”) increasing the indicated maximum daily dose of FIRDAPSE.
May 30, 2024
·
4 min read
Press Releases
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 27, 2025
·
17 min read
Press Releases
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
February 13, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
January 21, 2025
·
4 min read
Business
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today reported financial results for the first quarter of 2024 and provided a business update.
May 8, 2024
·
12 min read
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX) today announced that Richard J. Daly, CEO of Catalyst, along with other members of Catalyst’s management team, will participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium taking place virtually on April 2-3, 2024.
March 27, 2024
·
3 min read
Deals
Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
Catalyst Pharmaceuticals, Inc. (“Catalyst” or the “Company”) (Nasdaq: CPRX) announced today the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $15.00 per share.
January 5, 2024
·
4 min read
1 of 71,585
Next
